Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Determining Disease Activity Biomarkers in Individuals With Giant Cell Arteritis

Study:

Longitudinal Protocol for Giant Cell Arteritis

Rationale:

n/a

Purpose:

Giant cell arteritis (GCA), also known as temporal arteritis, is a disease that usually only occurs in older adults. GCA causes inflammation of blood vessels, or vasculitis. In order to properly treat this disease, it is critical that the level of disease activity can be determined over the course of the disease. The purpose of this study is to determine new biological markers, or biomarkers, that may be used to assess the severity of disease in people with GCA.

Study Status: Recruiting

Recruiting:
Katie Gartner 216-445-1397 gartnek@ccf.org

Condition Intervention Phase
Temporal Arteritis n/a N/A

Verified by University of Pennsylvania October, 2012

Sponsored by: University of Pennsylvania
Information provided by: University of Pennsylvania
ClinicalTrials.gov identifier: NCT00315497

Study Type: Interventional

Study Design: Observational Model: Cohort, Time Perspective: Prospective

Cleveland Clinic Foundation
Cleveland, Ohio 44195
United States

Peter A. Merkel, MD, MPH., Study Chair

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.